Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Franco Vega

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancers|September 13, 2025
From Emails to EMR: Implementing I-PASS Among Inpatient Palliative Care Clinicians at a Comprehensive Cancer Center-A Quality Improvement InitiativeJaya Amaram-Davila, Maria Franco Vega, Patricia Bramati, et al.
Clinical Lung Cancer|August 25, 2024
Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective AnalysisFelipe Soto-Lanza, Lydia Glick, Colin Chan, et al.
Journal of Pain and Symptom Management|September 1, 2024
Perceptions Toward Naloxone Among Patients With Cancer Receiving OpioidsJaya Amaram-Davila, Maria Franco Vega, Min Ji Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2025
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANSBingnan Zhang, Laura Alder, Samuel Rosner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 24, 2025
Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case ReportBingnan Zhang, Komal B Shah, Mitchell Parma, et al.
JCO Precision Oncology|April 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic ToxicityMitchell Parma, Kaiwen Wang, Ceylan Altintas Taslicay, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancers|September 13, 2025
From Emails to EMR: Implementing I-PASS Among Inpatient Palliative Care Clinicians at a Comprehensive Cancer Center-A Quality Improvement InitiativeJaya Amaram-Davila, Maria Franco Vega, Patricia Bramati, et al.
Clinical Lung Cancer|August 25, 2024
Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective AnalysisFelipe Soto-Lanza, Lydia Glick, Colin Chan, et al.
Journal of Pain and Symptom Management|September 1, 2024
Perceptions Toward Naloxone Among Patients With Cancer Receiving OpioidsJaya Amaram-Davila, Maria Franco Vega, Min Ji Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2025
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANSBingnan Zhang, Laura Alder, Samuel Rosner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 24, 2025
Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case ReportBingnan Zhang, Komal B Shah, Mitchell Parma, et al.
JCO Precision Oncology|April 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic ToxicityMitchell Parma, Kaiwen Wang, Ceylan Altintas Taslicay, et al.
Pageof 1